Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TPM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FOXD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
INSL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NOS1AP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATXN7L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
PTPN5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LMF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC105375839 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
C5orf51 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TUBGCP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAS2R19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF765 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPR162 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADAMTS15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRKAG2-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMARCC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on